Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Conferences

10 Jan 2019 - 11 Jan 2019

Oddo BHF Forum, Lyon, France

07 Jan 2019 - 10 Jan 2019

37th Annual J.P. Morgan Healthcare Conference, San Francisco (CA), USA

06 Nov 2018 - 08 Nov 2018

World Orphan Drug Congress Europe, Barcelona, Spain

12 October 2018

GenSight Biologics to present REVERSE data with GS010 at the 2018 Annual Meeting of the American Academy of Ophthalmology

09 October 2018

GenSight Biologics to participate in multiple upcoming investor conferences

22 Nov 2018 - 23 Nov 2018

Salon Actionaria 2018, Paris, France

23 Oct 2018 - 24 Oct 2018

2nd Annual Gene Therapy for Rare Disorders Europe, London, UK

25 Oct 2018

Ophthalmology Innovation Summit @ AAO, Chicago (IL)

27 Oct 2018 - 30 Oct 2018

American Academy of Ophthalmology, Chicago (IL)

09 Oct 2018

Chardan 2nd Annual Genetic Medicines Conference, NYC (US)

  • View previous 9 articles
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page